Kimberly Kallianos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kimberly Kallianos has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Brett M. Elicker
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA
4 shared publications - Karen Gomes Ordovas
Department of Radiology, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195-7117
4 shared publications - David M. Naeger
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA
3 shared publications - Brian M. Haas
Department of Radiology and Biomedical Imaging, University of California, San Francisco (UCSF), CA
2 shared publications - Jae Ho Sohn
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA
2 shared publications - Travis S. Henry
University of California San Francisco School of Medicine
2 shared publications
Latest Publications
- 2 September 2026
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 41 (6)
Effect of Rapid Rollover on Pneumothorax Rate After Percutaneous CT-Guided Lung Biopsy
Purpose: To evaluate whether the rapid rollover technique reduces new or enlarging pneumothorax after anterior or lateral approach CT-guided lung biopsy. Materials and Methods: A prospective, single-institution, multisite, RCT was undertaken after institutional review board approval. Patients with target lesions most amenable to the anterior/lateral approach were considered. Patients with extrapulmonary nodules, intraprocedural chest tube, or conditions that preclude safe repositioning were excluded. The primary outcome was new/enlarging pneumothorax on postbiopsy radiographs. Intention-to-treat (ITT) and per-protocol (PP) analyses were performed. Secondary outcomes, including chest tube insertion rate and patient discomfort, were also analyzed. Results: A total of 59 patients were recruited, with 28 randomized to the intervention arm and 31 to the control arm, without significant differences in patient demographics and risk factors. There were 8 cases or 13.6% of new/enlarging pneumothorax, 7 from the control arm and 1 from the intervention. One patient who developed pneumothorax in the intervention arm did not complete the maneuver. The difference in rates of new/enlarging pneumothorax was significant by both ITT and PP analyses ( P =0.03 and 0.009). Only 2 patients required chest tube insertion, 1 in the control group and 1 who crossed over to the control group. Multivariate analysis was performed in the ITT analysis, with intervention as an independent significant factor ( P =0.0463). There were no significant differences in terms of postbiopsy discomfort. Conclusions: This randomized controlled trial showed that, without an increase in patient discomfort, the rapid rollover technique reduced the risk of new or enlarging pneumothorax after CT-guided lung biopsy via an anterior/lateral approach. Level of Evidence: Level I—randomized controlled trial.
- 2 September 2026
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 41 (6)
Effect of Rapid Rollover on Pneumothorax Rate After Percutaneous CT-Guided Lung Biopsy
Purpose: To evaluate whether the rapid rollover technique reduces new or enlarging pneumothorax after anterior or lateral approach CT-guided lung biopsy. Materials and Methods: A prospective, single-institution, multisite, RCT was undertaken after institutional review board approval. Patients with target lesions most amenable to the anterior/lateral approach were considered. Patients with extrapulmonary nodules, intraprocedural chest tube, or conditions that preclude safe repositioning were excluded. The primary outcome was new/enlarging pneumothorax on postbiopsy radiographs. Intention-to-treat (ITT) and per-protocol (PP) analyses were performed. Secondary outcomes, including chest tube insertion rate and patient discomfort, were also analyzed. Results: A total of 59 patients were recruited, with 28 randomized to the intervention arm and 31 to the control arm, without significant differences in patient demographics and risk factors. There were 8 cases or 13.6% of new/enlarging pneumothorax, 7 from the control arm and 1 from the intervention. One patient who developed pneumothorax in the intervention arm did not complete the maneuver. The difference in rates of new/enlarging pneumothorax was significant by both ITT and PP analyses ( P =0.03 and 0.009). Only 2 patients required chest tube insertion, 1 in the control group and 1 who crossed over to the control group. Multivariate analysis was performed in the ITT analysis, with intervention as an independent significant factor ( P =0.0463). There were no significant differences in terms of postbiopsy discomfort. Conclusions: This randomized controlled trial showed that, without an increase in patient discomfort, the rapid rollover technique reduced the risk of new or enlarging pneumothorax after CT-guided lung biopsy via an anterior/lateral approach. Level of Evidence: Level I—randomized controlled trial.
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e250929
Telangiectatic Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
Telangiectatic pulmonary arteriovenous malformations, marked by ground-glass opacities with feeding arteries and draining veins, were common in patients with hereditary hemorrhagic telangiectasia and represent true right-to-left shunts.
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e250929
Telangiectatic Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
Telangiectatic pulmonary arteriovenous malformations, marked by ground-glass opacities with feeding arteries and draining veins, were common in patients with hereditary hemorrhagic telangiectasia and represent true right-to-left shunts.
- Open Access
- 1 March 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (3) , 436-451
Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement
Background: Lung cancer screening with low-dose computed tomography (LDCT) may uncover incidental findings (IFs) unrelated to lung cancer. There may be potential benefits from identifying clinically significant IFs that warrant intervention and potential harms related to identifying IFs that are not clinically significant but may result in additional evaluation, clinician effort, patient anxiety, complications, and excess cost. Objectives: To identify knowledge and research gaps and develop and prioritize research questions to address the approach to and management of IFs. Methods: We convened a multidisciplinary panel to review the available literature on IFs detected in lung cancer screening LDCT examinations, focusing on variability and standardizing reporting, management of IFs, and evaluation of the benefits and harms of IFs, particularly cardiovascular-related IFs. We used a three-round modified Delphi process to prioritize research questions. Results: This statement identifies knowledge gaps in 1) reporting of IFs, 2) management of IFs, and 3) identifying and reporting coronary artery calcification found on lung cancer screening LDCT. Finally, we present the panel’s initial 36 research questions and the final 20 prioritized questions. Conclusions: This statement provides a prioritized research agenda to further efforts focused on evaluating, managing, and increasing awareness of IFs in lung cancer screening.
- 1 March 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (3) , 436-451
Open AccessLung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement
Background: Lung cancer screening with low-dose computed tomography (LDCT) may uncover incidental findings (IFs) unrelated to lung cancer. There may be potential benefits from identifying clinically significant IFs that warrant intervention and potential harms related to identifying IFs that are not clinically significant but may result in additional evaluation, clinician effort, patient anxiety, complications, and excess cost. Objectives: To identify knowledge and research gaps and develop and prioritize research questions to address the approach to and management of IFs. Methods: We convened a multidisciplinary panel to review the available literature on IFs detected in lung cancer screening LDCT examinations, focusing on variability and standardizing reporting, management of IFs, and evaluation of the benefits and harms of IFs, particularly cardiovascular-related IFs. We used a three-round modified Delphi process to prioritize research questions. Results: This statement identifies knowledge gaps in 1) reporting of IFs, 2) management of IFs, and 3) identifying and reporting coronary artery calcification found on lung cancer screening LDCT. Finally, we present the panel’s initial 36 research questions and the final 20 prioritized questions. Conclusions: This statement provides a prioritized research agenda to further efforts focused on evaluating, managing, and increasing awareness of IFs in lung cancer screening.
- Open Access
- 26 February 2025
- Published by Springer Nature
- p. 69-81
Pulmonary Vascular Disease
Familiarity with the CT features of pulmonary vascular disease, including pulmonary embolism and pulmonary hypertension, is essential to ensure diagnostic accuracy. Acute and chronic pulmonary emboli have characteristic imaging findings; however, the diagnosis of pulmonary embolism can be challenging due to the high prevalence of image artifacts. Foreign materials may also embolize within the pulmonary arterial system. While relatively uncommon, pulmonary hypertension is disorder where accurate interpretation of CT imaging features is of critical importance. The World Health Organization (WHO) has defined a classification scheme with five groups of pulmonary hypertension patients. Characteristic lung parenchymal findings, in addition to pulmonary arterial abnormalities, are useful in distinguishing the etiology of pulmonary hypertension and in determining the most appropriate management.
- 26 February 2025
- Published by Springer Nature
- p. 69-81
Open AccessPulmonary Vascular Disease
Familiarity with the CT features of pulmonary vascular disease, including pulmonary embolism and pulmonary hypertension, is essential to ensure diagnostic accuracy. Acute and chronic pulmonary emboli have characteristic imaging findings; however, the diagnosis of pulmonary embolism can be challenging due to the high prevalence of image artifacts. Foreign materials may also embolize within the pulmonary arterial system. While relatively uncommon, pulmonary hypertension is disorder where accurate interpretation of CT imaging features is of critical importance. The World Health Organization (WHO) has defined a classification scheme with five groups of pulmonary hypertension patients. Characteristic lung parenchymal findings, in addition to pulmonary arterial abnormalities, are useful in distinguishing the etiology of pulmonary hypertension and in determining the most appropriate management.
- 26 June 2024
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 50 (3) , 409-422
Imaging of Pulmonary Manifestations of Connective Tissue Disease
- 26 June 2024
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 50 (3) , 409-422
Imaging of Pulmonary Manifestations of Connective Tissue Disease
- Open Access
- 8 February 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (3)
Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma
BACKGROUND: Information about the size, airway location, and longitudinal behavior of mucus plugs in asthma is needed to understand their role in mechanisms of airflow obstruction and to rationally design muco-active treatments. METHODS: CT lung scans from 57 patients with asthma were analyzed to quantify mucus plug size and airway location, and paired CT scans obtained 3 years apart were analyzed to determine plug behavior over time. Radiologist annotations of mucus plugs were incorporated in an image-processing pipeline to generate size and location information that was related to measures of airflow. RESULTS: The length distribution of 778 annotated mucus plugs was multimodal, and a 12 mm length defined short (“stubby”, ≤12 mm) and long (“stringy”, >12 mm) plug phenotypes. High mucus plug burden was disproportionately attributable to stringy mucus plugs. Mucus plugs localized predominantly to airway generations 6–9, and 47% of plugs in baseline scans persisted in the same airway for 3 years and fluctuated in length and volume. Mucus plugs in larger proximal generations had greater effects on spirometry measures than plugs in smaller distal generations, and a model of airflow that estimates the increased airway resistance attributable to plugs predicted a greater effect for proximal generations and more numerous mucus plugs. CONCLUSION: Persistent mucus plugs in proximal airway generations occur in asthma and demonstrate a stochastic process of formation and resolution over time. Proximal airway mucus plugs are consequential for airflow and are in locations amenable to treatment by inhaled muco-active drugs or bronchoscopy. TRIAL REGISTRATION: Clinicaltrials.gov; NCT01718197, NCT01606826, NCT01750411, NCT01761058, NCT01761630, NCT01716494, and NCT01760915. FUNDING: AstraZeneca, Boehringer-Ingelheim, Genentech, GlaxoSmithKline, Sanofi–Genzyme–Regeneron, and TEVA provided financial support for study activities at the Coordinating and Clinical Centers beyond the third year of patient follow-up. These companies had no role in study design or data analysis, and the only restriction on the funds was that they be used to support the SARP initiative.
- 8 February 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (3)
Open AccessPersistent mucus plugs in proximal airways are consequential for airflow limitation in asthma
BACKGROUND: Information about the size, airway location, and longitudinal behavior of mucus plugs in asthma is needed to understand their role in mechanisms of airflow obstruction and to rationally design muco-active treatments. METHODS: CT lung scans from 57 patients with asthma were analyzed to quantify mucus plug size and airway location, and paired CT scans obtained 3 years apart were analyzed to determine plug behavior over time. Radiologist annotations of mucus plugs were incorporated in an image-processing pipeline to generate size and location information that was related to measures of airflow. RESULTS: The length distribution of 778 annotated mucus plugs was multimodal, and a 12 mm length defined short (“stubby”, ≤12 mm) and long (“stringy”, >12 mm) plug phenotypes. High mucus plug burden was disproportionately attributable to stringy mucus plugs. Mucus plugs localized predominantly to airway generations 6–9, and 47% of plugs in baseline scans persisted in the same airway for 3 years and fluctuated in length and volume. Mucus plugs in larger proximal generations had greater effects on spirometry measures than plugs in smaller distal generations, and a model of airflow that estimates the increased airway resistance attributable to plugs predicted a greater effect for proximal generations and more numerous mucus plugs. CONCLUSION: Persistent mucus plugs in proximal airway generations occur in asthma and demonstrate a stochastic process of formation and resolution over time. Proximal airway mucus plugs are consequential for airflow and are in locations amenable to treatment by inhaled muco-active drugs or bronchoscopy. TRIAL REGISTRATION: Clinicaltrials.gov; NCT01718197, NCT01606826, NCT01750411, NCT01761058, NCT01761630, NCT01716494, and NCT01760915. FUNDING: AstraZeneca, Boehringer-Ingelheim, Genentech, GlaxoSmithKline, Sanofi–Genzyme–Regeneron, and TEVA provided financial support for study activities at the Coordinating and Clinical Centers beyond the third year of patient follow-up. These companies had no role in study design or data analysis, and the only restriction on the funds was that they be used to support the SARP initiative.
- Open Access
A Nomogram to Predict Pneumothorax Requiring Chest Tube Placement following Percutaneous CT-guided Lung Biopsy
Background Pneumothorax requiring chest tube after CT-guided transthoracic lung biopsy is one of the common complications, and the required hospital stay after chest tube placement represents an added clinical risk to patients and cost to the healthcare system. Identifying high-risk patients can prompt alternative biopsy modes and/or better preparation for more focused post-procedural care. Purpose To develop and externally validate a risk nomogram for pneumothorax requiring chest tube placement following CT-guided lung biopsy, leveraging quantitative emphysema algorithm. Materials & Methods This two-center retrospective study included patients who underwent CT-guided lung biopsy from between 1994 and 2023. Data from one hospital was set aside for validation (n=613). Emphysema severity was quantified and categorized to 3-point scale using a previously published algorithm based on 3×3×3 kernels and Hounsfield thresholding, and a risk calculator was developed using forward variable selection and logistic regression. The model was validated using bootstrapping and Harrell’s C-index. Results 2,512 patients (mean age, 64.47 years +/-13.38 [standard deviation]; 1250 men) were evaluated, of whom 157 (6.7%) experienced pneumothorax complications requiring chest tube placement. After forward variable selection to reduce the covariates to maximize clinical usability, the risk score was developed using age over 60 (OR 1.80 [1.15-2.93]), non-prone patient position (OR 2.48 [1.63-3.75]), and severe emphysema (OR 1.99 [1.35-2.94]). The nomogram showed mean absolute error of 0.5% in calibration and Harrell’s C-index of 0.664 in discrimination in the internal cohort. Conclusion The developed nomogram predicts age over 60, non-prone position during biopsy, and severe emphysema to be most predictive of pneumothorax requiring chest tube placement following CT-guided lung biopsy.
Open AccessA Nomogram to Predict Pneumothorax Requiring Chest Tube Placement following Percutaneous CT-guided Lung Biopsy
Background Pneumothorax requiring chest tube after CT-guided transthoracic lung biopsy is one of the common complications, and the required hospital stay after chest tube placement represents an added clinical risk to patients and cost to the healthcare system. Identifying high-risk patients can prompt alternative biopsy modes and/or better preparation for more focused post-procedural care. Purpose To develop and externally validate a risk nomogram for pneumothorax requiring chest tube placement following CT-guided lung biopsy, leveraging quantitative emphysema algorithm. Materials & Methods This two-center retrospective study included patients who underwent CT-guided lung biopsy from between 1994 and 2023. Data from one hospital was set aside for validation (n=613). Emphysema severity was quantified and categorized to 3-point scale using a previously published algorithm based on 3×3×3 kernels and Hounsfield thresholding, and a risk calculator was developed using forward variable selection and logistic regression. The model was validated using bootstrapping and Harrell’s C-index. Results 2,512 patients (mean age, 64.47 years +/-13.38 [standard deviation]; 1250 men) were evaluated, of whom 157 (6.7%) experienced pneumothorax complications requiring chest tube placement. After forward variable selection to reduce the covariates to maximize clinical usability, the risk score was developed using age over 60 (OR 1.80 [1.15-2.93]), non-prone patient position (OR 2.48 [1.63-3.75]), and severe emphysema (OR 1.99 [1.35-2.94]). The nomogram showed mean absolute error of 0.5% in calibration and Harrell’s C-index of 0.664 in discrimination in the internal cohort. Conclusion The developed nomogram predicts age over 60, non-prone position during biopsy, and severe emphysema to be most predictive of pneumothorax requiring chest tube placement following CT-guided lung biopsy.
- 2 September 2022
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 60 (6) , 915-924
Imaging of Pulmonary Manifestations of Connective Tissue Disease
- 2 September 2022
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 60 (6) , 915-924
Imaging of Pulmonary Manifestations of Connective Tissue Disease
- 1 December 2020
- Published by Elsevier in Clinical Imaging
- Vol. 68, 57-60
A case of acute onset gigantomastia in a 20-year-old woman
- 1 December 2020
- Published by Elsevier in Clinical Imaging
- Vol. 68, 57-60
A case of acute onset gigantomastia in a 20-year-old woman
- 1 July 2020
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 58 (4) , 721-731
Imaging Thoracic Aortic Aneurysm
- 1 July 2020
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 58 (4) , 721-731
Imaging Thoracic Aortic Aneurysm